References
- McLaughlin C, Kim NK, Bandyopadhyay D, Deng X, Kaplan B, Matin K, et al. 2019. Adjuvant radiation therapy for T4 non-rectal colon adenocarcinoma provides a cause-specific survival advantage: A SEER database analysis. Radiother. Oncol. 133: 50-53. https://doi.org/10.1016/j.radonc.2018.11.026
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68: 394-424. https://doi.org/10.3322/caac.21492
- Wei Z, Xu A, Han W, Chen Z. 2018. [Analysis of risk factors on vascular invasion in patients with early gastric cancer]. Zhonghua Wei Chang Wai Ke Za Zhi 21: 803-807.
- Liu J, Liu F, Li X, Song X, Zhou L, Jie J. 2017. Screening key genes and miRNAs in early-stage colon adenocarcinoma by RNAsequencing. Tumour Biol. 39: 1010428317714899.
- Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR. 2012. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 143: 844-857. https://doi.org/10.1053/j.gastro.2012.06.001
- Yan Y, Liu H, Mao K, Zhang M, Zhou Q, Yu W, et al. 2019. Novel nomograms to predict lymph node metastasis and liver metastasis in patients with early colon carcinoma. J. Transl. Med. 17: 193.
- Tang Q, Hann SS. 2018. HOTAIR: An oncogenic long non-coding RNA in human cancer. Cell. Physiol. Biochem. 47: 893-913. https://doi.org/10.1159/000490131
- Kopp F, Mendell JT. 2018. Functional classification and experimental dissection of long noncoding RNAs. Cell 172: 393-407. https://doi.org/10.1016/j.cell.2018.01.011
- Peng WX, Koirala P, Mo YY. 2017. LncRNA-mediated regulation of cell signaling in cancer. Oncogene 36: 5661-5667. https://doi.org/10.1038/onc.2017.184
- Bhan A, Soleimani M, Mandal SS. 2017. Long noncoding RNA and cancer: A new paradigm. Cancer Res. 77: 3965-3981. https://doi.org/10.1158/0008-5472.CAN-16-2634
- Ma Y, Zhang J, Wen L, Lin A. 2018. Membrane-lipid associated lncRNA: A new regulator in cancer signaling. Cancer Lett. 419: 27-29. https://doi.org/10.1016/j.canlet.2018.01.008
- Li Q, Lei C, Lu C, Wang J, Gao M, Gao W. 2019. LINC01232 exerts oncogenic activities in pancreatic adenocarcinoma via regulation of TM9SF2. Cell Death Dis. 10: 698.
- Meng LD, Shi GD, Ge WL, Huang XM, Chen Q, Yuan H, et al. 2020. Linc01232 promotes the metastasis of pancreatic cancer by suppressing the ubiquitin-mediated degradation of HNRNPA2B1 and activating the A-Raf-induced MAPK/ERK signaling pathway. Cancer Lett. 494: 107-120. https://doi.org/10.1016/j.canlet.2020.08.001
- Chen L, Zhou Y, Li H. 2018. LncRNA, miRNA and lncRNA-miRNA interaction in viral infection. Virus Res. 257: 25-32. https://doi.org/10.1016/j.virusres.2018.08.018
- Huang Y. 2018. The novel regulatory role of lncRNA-miRNA-mRNA axis in cardiovascular diseases. J. Cell. Mol. Med. 22: 5768-5775. https://doi.org/10.1111/jcmm.13866
- Zhao M, Cui H, Zhao B, Li M, Man H. 2020. Long intergenic non-coding RNA LINC01232 contributes to esophageal squamous cell carcinoma progression by sequestering microRNA-654-3p and consequently promoting hepatoma-derived growth factor expression. Int. J. Mol. Med. 46: 2007-2018. https://doi.org/10.3892/ijmm.2020.4750
- Shang A, Wang W, Gu C, Chen W, Lu W, Sun Z, et al. 2020. Long non-coding RNA CCAT1 promotes colorectal cancer progression by regulating miR-181a-5p expression. Aging 12: 8301-8320. https://doi.org/10.18632/aging.103139
- Qi X, Lin Y, Liu X, Chen J, Shen B. 2020. Biomarker discovery for the carcinogenic heterogeneity between colon and rectal cancers based on lncRNA-associated ceRNA network analysis. Front. Oncol. 10: 535985.
- Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods (San Diego, Calif.). 25: 402-408. https://doi.org/10.1006/meth.2001.1262
- Chen S, Shen X. 2020. Long noncoding RNAs: functions and mechanisms in colon cancer. Mol. Cancer 19: 167.
- Mizerska-Kowalska M, Bojarska-Junak A, Jakubowicz-Gil J, Kandefer-Szerszen M. 2016. Neutral endopeptidase (NEP) is differentially involved in biological activities and cell signaling of colon cancer cell lines derived from various stages of tumor development. Tumour Biol. 37: 13355-13368. https://doi.org/10.1007/s13277-016-5248-y
- Rokavec M, Horst D, Hermeking H. 2017. Cellular model of colon cancer progression reveals signatures of mRNAs, miRNA, lncRNAs, and epigenetic modifications associated with metastasis. Cancer Res. 77: 1854-1867. https://doi.org/10.1158/0008-5472.CAN-16-3236
- Wang SY, Li JY, Xu JH, Xia ZS, Cheng D, Zhong W, et al. 2019. Butyrate suppresses abnormal proliferation in colonic epithelial cells under diabetic state by targeting HMGB1. J. Pharmacol. Sci. 139: 266-274. https://doi.org/10.1016/j.jphs.2018.07.012
- Hong B, van den Heuvel AP, Prabhu VV, Zhang S, El-Deiry WS. 2014. Targeting tumor suppressor p53 for cancer therapy: strategies, challenges and opportunities. Curr. Drug Targets 15: 80-89. https://doi.org/10.2174/1389450114666140106101412
- Wang XW, Harris CC. 1997. p53 tumor-suppressor gene: clues to molecular carcinogenesis. J. Cell. Physiol. 173: 247-255. https://doi.org/10.1002/(SICI)1097-4652(199711)173:2<247::AID-JCP30>3.0.CO;2-A
- Brachtendorf S, Wanger RA, Birod K, Thomas D, Trautmann S, Wegner MS, et al. 2018. Chemosensitivity of human colon cancer cells is influenced by a p53-dependent enhancement of ceramide synthase 5 and induction of autophagy. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1863: 1214-1227. https://doi.org/10.1016/j.bbalip.2018.07.011
- Moriichi K, Fujiya M, Kobayashi Y, Murakami Y, Iwama T, Kunogi T, et al. 2019. Autofluorescence imaging reflects the nuclear enlargement of tumor cells as well as the cell proliferation ability and aberrant status of the p53, Ki-67, and p16 genes in colon neoplasms. Molecules 24: 1106.
- Valentini A, Gravina P, Federici G, Bernardini S. 2007. Valproic acid induces apoptosis, p16INK4A upregulation and sensitization to chemotherapy in human melanoma cells. Cancer Biol. Ther. 6: 185-191. https://doi.org/10.4161/cbt.6.2.3578
- Wei Y, Huang C, Wu H, Huang J. 2019. Estrogen Receptor Beta (ERβ) mediated-cyclinD1 degradation via autophagy plays an antiproliferation role in colon cells. Int. J. Biol. Sci. 15: 942-952. https://doi.org/10.7150/ijbs.30930
- Thompson EB. 1998. The many roles of c-Myc in apoptosis. Ann. Rev. Physiol. 60: 575-600. https://doi.org/10.1146/annurev.physiol.60.1.575
- Ebrahim AS, Sabbagh H, Liddane A, Raufi A, Kandouz M, Al-Katib A. 2016. Hematologic malignancies: newer strategies to counter the BCL-2 protein. J. Cancer Res. Clin. Oncol. 142: 2013-2022. https://doi.org/10.1007/s00432-016-2144-1
- Ramjiawan RR, Griffioen AW, Duda DG. 2017. Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy? Angiogenesis 20: 185-204. https://doi.org/10.1007/s10456-017-9552-y
- Apte RS, Chen DS, Ferrara N. 2019. VEGF in signaling and disease: Beyond discovery and development. Cell 176: 1248-1264. https://doi.org/10.1016/j.cell.2019.01.021
- Jiang Z, Zhang H, Bockmann RA. 2016. Allostery in BAX protein activation. J. Biomol. Struct. Dyn. 34: 2469-2480. https://doi.org/10.1080/07391102.2015.1119731
- Matsumoto K, Ema M. 2014. Roles of VEGF-A signalling in development, regeneration, and tumours. J. Biochem. 156: 1-10. https://doi.org/10.1093/jb/mvu031
- Lamouille S, Xu J, Derynck R. 2014. Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 15: 178-196. https://doi.org/10.1038/nrm3758
- Dongre A, Weinberg RA. 2019. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat. Rev. Mol. Cell Biol. 20: 69-84. https://doi.org/10.1038/s41580-018-0080-4
- Zeng M, Zhu L, Li L, Kang C. 2017. miR-378 suppresses the proliferation, migration and invasion of colon cancer cells by inhibiting SDAD1. Cell. Mol. Biol. Lett. 22: 12.